Clin2
NCT07737977Likely a fitNot yet recruiting

ALS biomarker study for monitoring disease progression

ALS (Amyotrophic Lateral Sclerosis)

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This study looks for biological markers in the blood or other samples to track how ALS progresses over time. The goal is to catch changes earlier, which could help in future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are aged 18 years or older.
  • You have been diagnosed with ALS by a doctor using standard criteria.
  • Your ALS is either inherited or not (sporadic or familial).
  • Your ALS started in the limbs or the bulbar region (speech/swallowing).
  • You are not currently in another trial with a waiting period, and you are willing to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07479017Not yet recruiting
Platelet biomarkers for ALS diagnosis

This study looks at blood platelets (tiny cells that help with clotting) in people with ALS and other motor neuron diseases. It aims to find new markers that could help diagnose ALS earlier. If you have a recent diagnosis, you may be able to join by giving a blood sample.

Limoges
NCT07400393Not yet recruiting
ALS genetic matching study

This study aims to match people with ALS to potential treatments based on their genetic profile. It connects you to a network of trials that may be relevant to your specific type of ALS.

NCT07099066Not yet recruiting
Collecting cells and biomarkers from ALS patients

This study collects samples (blood, skin, urine) from people with ALS to create cell banks and find biomarkers. It helps researchers learn more about the disease and may lead to better treatments.

NCT07268833Recruiting
Finding new ALS biomarkers from nerve cells and blood

This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.

Monserrato, California
NCT07334743Recruiting
A study to find biomarkers in ALS using tiny brain particles

This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.

Paris
NCT07312240Recruiting
Biomarkers in ALS: A long-term study

This study is looking for people with ALS to help doctors understand how certain biological markers (biomarkers) change over time. It involves a lumbar puncture (spinal tap) to collect fluid from your spine and regular check-ups.

Milan, Lombardy

Hear when a new ALS (Amyotrophic Lateral Sclerosis) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.